A new $1.0M Seed funding round will help Bioscan Research advance its non-invasive technologies for early brain injury detection. The capital, secured from Unicorn India Ventures, is set to bolster the company's work on its flagship device, CEREBO®.
CEREBO® leverages near-infrared spectroscopy and adaptive machine learning to assist clinicians in detecting intracranial haemorrhage at the point of care. Designed for use across emergency, defence, and public health settings, the device addresses the critical need for rapid screening where access to CT imaging may be limited.


















